Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Telix Pharmaceuticals (Innovations) Pty Limited
Maastricht Radiation Oncology
National Cancer Institute (NCI)